부산대학교 도서관

Quiñones LA; Laboratory of Chemical Carcinogenesis and Pharmacogenetics (CQF), Department of Basic and Clinical Oncology, Faculty of Medicine, University of Chile, Santiago, Chile.; Department of Pharmaceutical Sciences and Technology, Faculty of Chemical and Pharmaceutical Sciences, University of Chile, Santiago, Chile.; Center for Cancer Prevention and Control (CECAN), Santiago, Chile.; Martínez MF; Laboratory of Advanced Research in Personalized Medicine, Department of Pharmaceutical Sciences and Technology, Faculty of Chemical and Pharmaceutical Sciences, University of Chile, Santiago, Chile.; Vargas R; Department of Molecular Biology, Galileo University, Guatemala, Guatemala.; Cerpa LC; Laboratory of Chemical Carcinogenesis and Pharmacogenetics (CQF), Department of Basic and Clinical Oncology, Faculty of Medicine, University of Chile, Santiago, Chile.; Center for Cancer Prevention and Control (CECAN), Santiago, Chile.; López-Cortés A; Cancer Research Group (CRG), Faculty of Medicine, Universidad de Las Américas, Quito, Ecuador.; González-Martínez F; Toxicology and Public Health Research Laboratory, Department of Research, Faculty of Dentistry, University of Cartagena, Cartagena, Colombia.; Fonseca D; Universidad del Rosario. School of Medicine and Health Sciences. Center for Research in Genetics and Genomics (CIGGUR), Institute of Translational Medicine (IMT), Bogotá, Colombia.; Duconge J; Department of Pharmaceutical Sciences, School of Pharmacy, University of Puerto Rico-Medical Sciences Campus, San Juan, PR, United States.; Varela NM; Laboratory of Chemical Carcinogenesis and Pharmacogenetics (CQF), Department of Basic and Clinical Oncology, Faculty of Medicine, University of Chile, Santiago, Chile.; Lares-Asseff I; Latin American Society of Pharmacogenomics and Personalized Medicine, Santiago, Chile.; Redal MA; Molecular Diagnostic Laboratory, Genetics Division. Faculty of Medicine, Hospital de Clínicas José de San Martín. University of Buenos Aires, Buenos Aires, Argentina.; Esperón P; Molecular Genetic Unit, School of Chemistry, Universidad de la República, Montevideo, Uruguay.; Ríos-Santos F; Department of Health. Faculty of Medicine, Federal University of Mato Grosso (UFMT), Cuiabá, Brazil.; Rendón AL; Department of Pharmaceutical Technology, National Autonomous University of Honduras, Tegucigalpa, Honduras.; Serrano R; PhV Latam, San Salvador, El Salvador.; Ortega E; Colegio de Bioquímica y Farmacia de Tarija, Tarija, Bolivia.; Sullón-Dextre L; Sociedad de Farmacología Molecular del Perú, Lima, Peru.; Sanchez E; Vivian Pellas Hospital, Managua, Nicaragua.; Arias ML; Tropical Diseases Research Center and Microbiology Faculty, University of Costa Rica, San José, Costa Rica.; Remírez D; National Centre for Quality Control of Drugs, La Havana, Cuba.; Morales A; Facultad de Farmacia, Universidad de Los Andes, Merida, Venezuela.

Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE

Cerpa LC; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago, Chile.; Latin American Network for Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF), Santiago, Chile.; Center for Cancer Prevention and Control (CECAN), Santiago, Chile.; Sandoval C; Clinical Laboratory, Felix Bulnes Clinical Hospital, Santiago, Chile.; Escalante P; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago, Chile.; Cayún JP; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago, Chile.; Latin American Network for Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF), Santiago, Chile.; Lavanderos MA; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago, Chile.; Latin American Network for Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF), Santiago, Chile.; Department of Basic Sciences, Faculty of Sciences, University of Bío, Bío, Chile.; Alarcón-Concha C; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago, Chile.; Escuela de Medicina, Fundación Instituto Profesional Duoc UC, Santiago, Chile.; Kaempfe G; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago, Chile.; Moreno-Tapia D; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago, Chile.; Quiroz CS; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago, Chile.; Gutierrez-Cáceres C; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago, Chile.; Department of Pharmaceutical Sciences and Technology, Faculty of Chemical and Pharmaceutical Sciences, University of Chile, Santiago, Chile.; Barajas O; Center for Cancer Prevention and Control (CECAN), Santiago, Chile.; Clinical Hospital of University of Chile, Santiago, Chile.; Müller B; Center for Cancer Prevention and Control (CECAN), Santiago, Chile.; National Cancer Institute, Santiago, Chile.; Colombo A; Center for Cancer Prevention and Control (CECAN), Santiago, Chile.; Biobank of Fluids and Tissues of the University of Chile, Santiago, Chile.; Donoso G; Center for Cancer Prevention and Control (CECAN), Santiago, Chile.; Biobank of Fluids and Tissues of the University of Chile, Santiago, Chile.; Nuñez A; Faculty of Pharmacy, University of Costa Rica, San Jose, Costa Rica.; Varela NM; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago, Chile.; Latin American Network for Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF), Santiago, Chile.; Quiñones LA; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago, Chile.; Latin American Network for Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF), Santiago, Chile.; Department of Pharmaceutical Sciences and Technology, Faculty of Chemical and Pharmaceutical Sciences, University of Chile, Santiago, Chile.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

D'Afonseca, Vívian; Arencibia, Ariel D; Echeverría-Vega, Alex; Cerpa, Leslie; Cayún, Juan P; Varela, Nelson M; Salazar, Marcela; Quiñones, Luis A

Cancer Informatics. 5/25/2020, Vol. 19, p1-14. 14p.

Quiñones LA; Departamento de Oncología Básico Clínica, Facultad de Medicina, Universidad de Chile, Santiago, Chile.

Publisher: Sociedad Médica de Santiago Country of Publication: Chile NLM ID: 0404312 Publication Model: Print Cited Medium: Internet ISSN: 0717-6163 (Electronic) Linking ISSN: 00349887 NLM ISO Abbreviation: Rev Med Chil Subsets: MEDLINE; In Process

Echeverría-Garcés G; Centro de Referencia Nacional de Genómica, Secuenciación y Bioinformática, Instituto Nacional de Investigación en Salud Pública 'Leopoldo Izquieta Pérez', Quito, Ecuador.; Latin American Network for the Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Santiago, Chile.; Ramos-Medina MJ; German Cancer Research Center (DKFZ), Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.; Vargas R; Latin American Network for the Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Santiago, Chile.; Department of Molecular Biology, Galileo University, Guatemala City, Guatemala.; Cabrera-Andrade A; Escuela de Enfermería, Facultad de Ciencias de La Salud, Universidad de Las Américas, Quito, Ecuador.; Grupo de Bio-Quimioinformática, Universidad de Las Américas, Quito, Ecuador.; Altamirano-Colina A; Cancer Research Group (CRG), Faculty of Medicine, Universidad de Las Américas, Quito, Ecuador.; Freire MP; Cancer Research Group (CRG), Faculty of Medicine, Universidad de Las Américas, Quito, Ecuador.; Montalvo-Guerrero J; Cancer Research Group (CRG), Faculty of Medicine, Universidad de Las Américas, Quito, Ecuador.; Rivera-Orellana S; Facultad de Ingenierías y Ciencias Aplicadas, Universidad Internacional SEK, Quito, Ecuador.; Echeverría-Espinoza P; Cancer Research Group (CRG), Faculty of Medicine, Universidad de Las Américas, Quito, Ecuador.; Quiñones LA; Latin American Network for the Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Santiago, Chile.; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago, Chile.; Department of Pharmaceutical Sciences and Technology, Faculty of Chemical and Pharmaceutical Sciences, University of Chile, Santiago, Chile.; López-Cortés A; Cancer Research Group (CRG), Faculty of Medicine, Universidad de Las Américas, Quito, Ecuador.

Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE

Escalante PI; Laboratory of Chemical Carcinogenesis and Pharmacogenetics (CQF), Department of Basic and Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago, Chile.; Laboratory of Cellular and Molecular Oncology (LOCYM), Department of Basic and Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago, Chile.; Quiñones LA; Laboratory of Chemical Carcinogenesis and Pharmacogenetics (CQF), Department of Basic and Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago, Chile.; Latin American Network for the Implementation and Validation of Pharmacogenomic Clinical Guidelines (RELIVAF), Santiago, Chile.; Department of Pharmaceutical Sciences and Technology, Faculty of Chemical and Pharmaceutical Sciences, University of Chile, Santiago, Chile.; Contreras HR; Laboratory of Cellular and Molecular Oncology (LOCYM), Department of Basic and Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago, Chile.; Center for Cancer Prevention and Control (CECAN), Santiago, Chile.

Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE

Amador JS; Intensive Care Unit, San Borja Arriarán Clinical Hospital, Santiago 8360160, Chile.; School of Chemistry and Pharmacy, Faculty of Medicine, Universidad Andrés Bello, Santiago 8320000, Chile.; Vega Á; CleanDrugs®, Hospitales y Atención Sanitaria, Concepción 4030000, Chile.; Araos P; Hypertension and Kidney Immunology Laboratory, Institute of Biomedical Science, Universidad Autónoma de Chile, Santiago 8910060, Chile.; Quiñones LA; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology, Faculty of Medicine, Universidad de Chile, Santiago 8500000, Chile.; Department of Technology and Pharmaceutical Sciences, Faculty of Chemical and Pharmaceutical Sciences, University of Chile, Santiago 8380000, Chile.; Latin American Network for Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF), Santiago 8500000, Chile.; Amador CA; Faculty of Medicine and Science, Universidad San Sebastián, Santiago 7510157, Chile.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238453 Publication Model: Electronic Cited Medium: Print ISSN: 1424-8247 (Print) Linking ISSN: 14248247 NLM ISO Abbreviation: Pharmaceuticals (Basel) Subsets: PubMed not MEDLINE

Martinez, Matias F; Alveal, Enzo; Soto, Tomas G; Bustamante, Eva I; Ávila, Fernanda; Bangdiwala, Shrikant I; Flores, Ivonne; Benavides, Claudia; Morales, Ricardo; Varela, Nelson M; Quiñones, Luis A

Pharmacogenomics & Personalized Medicine; Aug2020, Vol. 13, p337-343, 7p

Sanhueza S; Molecular and Translational Immunology Laboratory, Department of Clinical Biochemistry and Immunology, Pharmacy Faculty, University of Concepción, Concepción, Chile.; Vidal MA; Molecular and Translational Immunology Laboratory, Department of Clinical Biochemistry and Immunology, Pharmacy Faculty, University of Concepción, Concepción, Chile.; Facultad de Ingeniería, Diseño y Arquitectura, Universidad San Sebastián, Concepción, Chile.; Hernandez MA; Division of Biotechnology, MELISA Institute, San Pedro de la Paz, Chile.; Henriquez-Beltran ME; Molecular and Translational Immunology Laboratory, Department of Clinical Biochemistry and Immunology, Pharmacy Faculty, University of Concepción, Concepción, Chile.; Núcleo de Investigación en Ciencias de la Salud, Universidad Adventista de Chile, Chillán, Chile.; Kinesiology School, Escuela de Kinesiología, Facultad de Salud, Universidad Santo Tomás, Los Ángeles, Chile.; Translational Research in Respiratory Medicine, University Hospital Arnau de Vilanova and Santa Maria, IRBLleida, Lleida, Spain.; Cabrera C; Molecular and Translational Immunology Laboratory, Department of Clinical Biochemistry and Immunology, Pharmacy Faculty, University of Concepción, Concepción, Chile.; Quiroga R; Molecular and Translational Immunology Laboratory, Department of Clinical Biochemistry and Immunology, Pharmacy Faculty, University of Concepción, Concepción, Chile.; Antilef BE; Molecular and Translational Immunology Laboratory, Department of Clinical Biochemistry and Immunology, Pharmacy Faculty, University of Concepción, Concepción, Chile.; Aguilar KP; Molecular and Translational Immunology Laboratory, Department of Clinical Biochemistry and Immunology, Pharmacy Faculty, University of Concepción, Concepción, Chile.; Castillo DA; Molecular and Translational Immunology Laboratory, Department of Clinical Biochemistry and Immunology, Pharmacy Faculty, University of Concepción, Concepción, Chile.; Llerena FJ; Molecular and Translational Immunology Laboratory, Department of Clinical Biochemistry and Immunology, Pharmacy Faculty, University of Concepción, Concepción, Chile.; Fraga Figueroa M; Molecular and Translational Immunology Laboratory, Department of Clinical Biochemistry and Immunology, Pharmacy Faculty, University of Concepción, Concepción, Chile.; Nazal M; Molecular and Translational Immunology Laboratory, Department of Clinical Biochemistry and Immunology, Pharmacy Faculty, University of Concepción, Concepción, Chile.; Castro E; Molecular and Translational Immunology Laboratory, Department of Clinical Biochemistry and Immunology, Pharmacy Faculty, University of Concepción, Concepción, Chile.; Lagos P; Molecular and Translational Immunology Laboratory, Department of Clinical Biochemistry and Immunology, Pharmacy Faculty, University of Concepción, Concepción, Chile.; Moreno A; Molecular and Translational Immunology Laboratory, Department of Clinical Biochemistry and Immunology, Pharmacy Faculty, University of Concepción, Concepción, Chile.; Lastra JJ; Internal Medicine Department, Hospital Guillermo Grant Benavente and Medicine Faculty, University of Concepción, Concepción, Chile.; Gajardo J; Internal Medicine Department, Hospital Guillermo Grant Benavente and Medicine Faculty, University of Concepción, Concepción, Chile.; Garcés P; Internal Medicine Department, Hospital Guillermo Grant Benavente and Medicine Faculty, University of Concepción, Concepción, Chile.; Riffo B; PreveGen Laboratory, Concepción, Chile.; Buchert J; PreveGen Laboratory, Concepción, Chile.; Sanhueza R; Kinesiology School, Escuela de Kinesiología, Facultad de Salud, Universidad Santo Tomás, Los Ángeles, Chile.; Ormazába V; Department of Pharmacology, Faculty of Biological Sciences, University of Concepción, Concepción, Chile.; Saldivia P; Division of Biotechnology, MELISA Institute, San Pedro de la Paz, Chile.; Vargas C; Division of Biotechnology, MELISA Institute, San Pedro de la Paz, Chile.; Nourdin G; Division of Biotechnology, MELISA Institute, San Pedro de la Paz, Chile.; Koch E; Division of Biotechnology, MELISA Institute, San Pedro de la Paz, Chile.; Zuñiga FA; Molecular and Translational Immunology Laboratory, Department of Clinical Biochemistry and Immunology, Pharmacy Faculty, University of Concepción, Concepción, Chile.; Lamperti L; Molecular and Translational Immunology Laboratory, Department of Clinical Biochemistry and Immunology, Pharmacy Faculty, University of Concepción, Concepción, Chile.; Bustos P; Molecular and Translational Immunology Laboratory, Department of Clinical Biochemistry and Immunology, Pharmacy Faculty, University of Concepción, Concepción, Chile.; Guzmán-Gutiérrez E; Molecular and Translational Immunology Laboratory, Department of Clinical Biochemistry and Immunology, Pharmacy Faculty, University of Concepción, Concepción, Chile.; Tapia CA; Molecular and Translational Immunology Laboratory, Department of Clinical Biochemistry and Immunology, Pharmacy Faculty, University of Concepción, Concepción, Chile.; Ferrada L; CMA Bío-Bío - Advanced Microscopy Center, University of Concepción, Concepción, Chile.; Cerda G; CMA Bío-Bío - Advanced Microscopy Center, University of Concepción, Concepción, Chile.; Woehlbier U; Center for Integrative Biology, Faculty of Sciences, Universidad Mayor, Santiago, Chile.; Riquelme E; Faculty of Medicine, Pontifical Catholic University of Chile, Santiago, Chile.; Yuseff MI; Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile.; Muñoz Ramirez BA; Department of Pharmacology and Toxicology, School of Medicine, Indiana University Bloomington, Bloomington, IN, United States.; Lombardi G; Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.; De Gonzalo-Calvo D; Translational Research in Respiratory Medicine, University Hospital Arnau de Vilanova and Santa Maria, IRBLleida, Lleida, Spain.; CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain.; Salomon C; Exosome Biology Laboratory, Centre for Clinical Diagnostics, UQ Centre for Clinical Research, Royal Brisbane and Women's Hospital, Medicine and Biomedical Science Faculty, The University of Queensland, Brisbane, QLD, Australia.; Verdugo RA; Instituto de Investigación Interdisciplinaria y Escuela de Medicina, Universidad de Talca, Talca, Chile.; Quiñones LA; Department of Basic-Clinical Oncology, Faculty of Medicine, University of Chile, Santiago, Chile.; Department of Pharmaceutical Sciences and Technology, Faculty of Chemical and Pharmaceutical Sciences, University of Chile, Santiago, Chile.; Latin American Network for Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Santiago, Chile.; Colombo A; Department of Basic-Clinical Oncology, Faculty of Medicine, University of Chile, Santiago, Chile.; Servicio de Anatomía Patológica, Hospital Clínico, Universidad de Chile, Santiago, Chile.; Barría MI; Facultad de Medicina y Ciencia, Universidad San Sebastián, Puerto Montt, Chile.; Labarca G; Molecular and Translational Immunology Laboratory, Department of Clinical Biochemistry and Immunology, Pharmacy Faculty, University of Concepción, Concepción, Chile.; Internal Medicine, Complejo Asistencial Dr. Víctor Ríos Ruiz, Los Ángeles, Chile.; Division of Sleep and Circadian Disorders, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.; Nova-Lamperti E; Molecular and Translational Immunology Laboratory, Department of Clinical Biochemistry and Immunology, Pharmacy Faculty, University of Concepción, Concepción, Chile.

Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101648047 Publication Model: eCollection Cited Medium: Print ISSN: 2296-858X (Print) Linking ISSN: 2296858X NLM ISO Abbreviation: Front Med (Lausanne) Subsets: PubMed not MEDLINE

Young, Rodrigo M; Solis, Camila J; Barriga-Fehrman, Andres; Abogabir, Carlos; Thadani, Alvaro R; Labarca, Mariana; Bustamante, Eva; Tapia, Cecilia V; Sarda, Antonia G; Sepulveda, Francisca; Pozas, Nadia; Cerpa, Leslie C; Lavanderos, María A; Varela, Nelson M; Santibañez, Alvaro; Sandino, Ana M; Reyes-Lopez, Felipe; Dixon, Garth; Quiñones, Luis A

eLife. June 22, 2021, Vol. 10

Agúndez JAG; Institute of Molecular Pathology Biomarkers, University of Extremadura, Cáceres, Spain.; Ayuso P; Institute of Molecular Pathology Biomarkers, University of Extremadura, Cáceres, Spain.; Quiñones LA; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago, Chile.; Latin American Network for Implementation and Validation of Clinical Pharmacogenomic Guidelines (RELIVAFCYTED), Santiago, Chile.; García-Martín E; Institute of Molecular Pathology Biomarkers, University of Extremadura, Cáceres, Spain.

Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE

Gutiérrez-Cáceres C; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago 8350499, Chile.; Department of Pharmaceutical Sciences and Technology, Faculty of Chemical and Pharmaceutical Sciences, University of Chile, Santiago 8350499, Chile.; Ávila N; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago 8350499, Chile.; Cerpa LC; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago 8350499, Chile.; Latin American Network for Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Santiago 8350499, Chile.; Martínez MF; Department of Pharmaceutical Sciences and Technology, Faculty of Chemical and Pharmaceutical Sciences, University of Chile, Santiago 8350499, Chile.; Latin American Network for Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Santiago 8350499, Chile.; Irarrazabal CE; Laboratory of Molecular and Integrative Physiology, Physiology Program, Centro de Investigación e Innovación Biomédica (CiiB), Universidad de los Andes, Santiago 7620086, Chile.; Torres B; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago 8350499, Chile.; Department of Pharmaceutical Sciences and Technology, Faculty of Chemical and Pharmaceutical Sciences, University of Chile, Santiago 8350499, Chile.; Barajas O; Department of Oncology, University of Chile Clinical Hospital (HCUCH), Santiago 8380453, Chile.; Varela NM; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago 8350499, Chile.; Latin American Network for Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Santiago 8350499, Chile.; Quiñones LA; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago 8350499, Chile.; Department of Pharmaceutical Sciences and Technology, Faculty of Chemical and Pharmaceutical Sciences, University of Chile, Santiago 8350499, Chile.; Latin American Network for Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Santiago 8350499, Chile.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238453 Publication Model: Electronic Cited Medium: Print ISSN: 1424-8247 (Print) Linking ISSN: 14248247 NLM ISO Abbreviation: Pharmaceuticals (Basel) Subsets: PubMed not MEDLINE

Salas-Hernández A; Department of Pharmacology, Toxicology and Pharmaco-Dependence, Faculty of Pharmacy, University of Costa Rica, San Jose, Costa Rica.; Galleguillos M; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago, Chile.; Carrasco M; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago, Chile.; López-Cortés A; Cancer Research Group (CRG), Faculty of Medicine, Universidad de Las Américas, Quito, Ecuador.; Redal MA; Molecular Diagnostic Laboratory, Genetics Division, Faculty of Medicine, Hospital de Clínicas José de San Martín, University of Buenos Aires, Buenos Aires, Argentina.; Fonseca-Mendoza D; Universidad del Rosario, School of Medicine and Health Sciences, Center for Research in Genetics and Genomics (CIGGUR), Institute of Translational Medicine (IMT), Bogotá, Colombia.; Esperón P; Molecular Genetic Unit, School of Chemistry, Universidad de la República, General Flores, CP 1800 2124, Montevideo, Uruguay.; González-Martínez F; Toxicology and Public Health Research Laboratory, Department of Research, Faculty of Dentistry, University of Cartagena, Cartagena, Colombia.; Lares-Asseff I; Academy of Genomics and Laboratory of Pharmacogenomics and Molecular Biomedicine, Instituto Politécnico Nacional, CIIDIR-Unidad Durango, Durango, Mexico.; Lazarowski A; Instituto de Fisiopatología y Bioquímica Clínica (INFIBIOC), Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires- Argentina, Buenos Aires, Argentina.; Loera-Castañeda V; Academy of Genomics and Laboratory of Pharmacogenomics and Molecular Biomedicine, Instituto Politécnico Nacional, CIIDIR-Unidad Durango, Durango, Mexico.; Remírez D; National Centre for Quality Control of Drugs, La Havana, Cuba.; Martínez MF; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago, Chile.; Department of Pharmaceutical Sciences and Technology, Faculty of Chemical and Pharmaceutical Sciences, University of Chile, Santiago, Chile.; Vargas R; Department of Molecular Biology, Galileo University, Guatemala City, Guatemala.; Rios-Santos F; Department of Health. Faculty of Medicine, Federal University of Mato Grosso (UFMT), Cuibá, Brazil.; Macho A; Morphology and Applied Immunology Research Center (NuPMIA), University of Brasilia (UnB), Brasília, Brazil.; Cayún JP; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago, Chile.; Perez GR; Department of Microbiology, Faculty of Biochemical and Pharmaceutical Sciences. National University of Rosario, Rosario, Argentina.; Gutierrez C; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago, Chile.; Cerpa LC; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago, Chile.; Leiva T; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago, Chile.; Calfunao S; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago, Chile.; Laboratory Pathological Anatomy, Hospital Luis Calvo Mackenna, Santiago, Chile.; Xajil L; Department of Research in Pharmacogenomics, Faculty of Chemical Sciences and Pharmacy, University of San Carlos de Guatemala, Guatemala, Guatemala.; Sandoval C; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago, Chile.; Clinical Laboratory Blood Biochemistry and Immunoassay Section, Hospital Clínico Félix Bulnes Cerda, Santiago, Chile.; Suárez M; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago, Chile.; Pharmacy Service, Hospital UC-Christus, Santiago, Chile.; Gonzalez A; Medical Genetics Platform, Santa Fe, Argentina.; Echeverría-Garcés G; Facultad de Ciencias de La Salud, Universidad Internacional de Valencia, Valencia, España.; Sullón-Dextre L; Sociedad de Farmacología Molecular del Perú, Lima, Perú.; Cordero-García E; Department of Pharmacology, Toxicology and Pharmaco-Dependence, Faculty of Pharmacy, University of Costa Rica, San Jose, Costa Rica.; Morales AR; Department of Toxicology and Pharmacology, Faculty of Pharmacy and Bioanalisis, University of Los Andes, Merida, Venezuela.; Avendaño A; Department of Pediatrics, Medical Genetics Unity, Faculty of Medicine, University of Los Andes, Mérida, Venezuela.; Sánchez E; Vivian Pellas Hospital, Managua, Nicaragua.; Bastone LC; Laboratorio de Medicina Genómica, Gammalab, Grupo Gamma, Rosario, Argentina.; Lara C; Betesda La Alternativa Natural, San José, Costa Rica.; Zuluaga-Arias P; Colombian Association of Pharmacovigilance, Bogotá, Colombia.; Soler AM; Laboratorio de Genética Molecular Humana, Departamento de Ciencias Biológicas, Universidad de La República, Montevideo, Uruguay.; Da Luz J; Laboratorio de Genética Molecular Humana, Departamento de Ciencias Biológicas, Universidad de La República, Montevideo, Uruguay.; Burgueño-Rodríguez G; Laboratorio de Genética Molecular Humana, Departamento de Ciencias Biológicas, Universidad de La República, Montevideo, Uruguay.; Vital M; Molecular Genetic Unit, School of Chemistry, Universidad de la República, General Flores 2124, Montevideo, Uruguay.; Reyes-Reyes E; Clinical Experimental Pharmacology Section, Teaching and Research Department, Institute of Oncology and Radiobiology, Havana, Cuba.; Huaccha A; Pharmacy Service, Hospital II 1 Moyobamba, San Martín, Perú.; Ariza YV; Pharmaceutical Chemistry Program, El Bosque University, Bogotá, Colombia.; Tzul N; Drug Inspectorate Unit, Ministry of Health and Wellness, Belmopan, Belize.; Rendón AL; Department of Pharmaceutical Technology, National Autonomous University of Honduras, Tegucigalpa, Honduras.; Serrano R; PhV Latam, San Salvador, El Salvador.; Acosta L; Faculty of Biology, Chemistry and Pharmacy, Galileo University, Guatemala, Guatemala.; Motta-Pardo A; GENOBIDC, Faculty of Pharmacy and Biochemistry, Universidad Nacional Mayor de San Marcos (UNMSM), CIGBM, Faculty of Medicine, Universidad de San Martin de Porres (USMP), Lima, Peru.; Beltrán-Angarita L; Faculty of Heath Sciences, Central Unit of Valle del Cauca, Tuluá, Colombia.; Chemistry School, Universidad Tecnológica de Pereira, Pereira, Colombia.; Brand E; Postgraduate Department, Master's Degree in Immunology, Universidad Cayetano Heredia, Lima, Perú.; Jiménez MA; Clinical Pharmaceutical Services, Health Division, Chillán, Chile.; Hidalgo-Lozada GM; Department of Physiology, Health Sciences University Center, University of Guadalajara, Guadalajara, Mexico.; Romero-Prado MMJ; Department of Physiology, Health Sciences University Center, University of Guadalajara, Guadalajara, Jalisco, Mexico.; Escobar-Castro K; Laboratory of Histocompatibility and Immunogenetics, Department of Nephrology and Transplant, Hospital General San Juan de Dios, Guatemala, Guatemala.; Umaña-Rivas M; Department of Tropical Medicine, Faculty of Medicine, University of Brasília, Brasília, Brazil.; Vivas JD; Department of Clinical Pharmacology, Faculty of Medicine, University of La Sabana, Chía, Colombia.; Lagos P; Recombinant Biopharmaceutical Laboratory, Department of Pharmacology, Faculty of Biological Sciences, University of Concepción, Concepción, Chile.; Martínez YB; Medical Specialist in Epidemiology Clinical Pharmacology Teacher; Medical Scientific and Pharmacovigilance Advisor in the Pharmaceutical Industry, Bogotá, Colombia.; Quesada S; Faculty of Pharmacy, University of Costa Rica, San Jose, Costa Rica.; Calfio C; International Center for Biomedicine ICC, Santiago, Chile.; Arias ML; Tropical Diseases Research Center and Microbiology Faculty, University of Costa Rica, San José, Costa Rica.; Lavanderos MA; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago, Chile.; Cáceres DD; Environmental Health Programme, School of Public Health, Faculty of Medicine, University of Chile, Santiago, Chile.; Salazar-Granara A; Universidad de San Martín de Porres, Facultad de Medicina Humana, Centro de Investigación de Medicina Tradicional y Farmacología, Lima, Perú.; Varela NM; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago, Chile.; Quiñones LA; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago, Chile.; Department of Pharmaceutical Sciences and Technology, Faculty of Chemical and Pharmaceutical Sciences, University of Chile, Santiago, Chile.

Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE

López-Cortés A; Cancer Research Group (CRG), Faculty of Medicine, Universidad de Las Américas, Quito, Ecuador.; Latin American Network for the Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Santiago, Chile.; Esperón P; Latin American Network for the Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Santiago, Chile.; Molecular Genetics Laboratory, Clinical Biochemistry Department, School of Chemistry, Universidad de la República, Montevideo, Uruguay.; Martínez MF; Latin American Network for the Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Santiago, Chile.; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago, Chile.; Department of Pharmaceutical Science and Technology, Faculty of Chemical and Pharmaceutical Sciences, University of Chile, Santiago, Chile.; Redal MA; Latin American Network for the Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Santiago, Chile.; Genetic Division, Department of Medicine, Faculty of Medicine, Hospital de Clínicas José de San Martín, Buenos Aires University, Buenos Aires, Argentina.; Clinical Biochemistry Department, Faculty of Pharmacy and Biochemistry, Institute for Research in Physiopathology and Clinical Biochemistry (INFIBIOC), Hospital de Clínicas José de San Martín, University of Buenos Aires, Buenos Aires, Argentina.; Lazarowski A; Latin American Network for the Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Santiago, Chile.; Clinical Biochemistry Department, Faculty of Pharmacy and Biochemistry, Institute for Research in Physiopathology and Clinical Biochemistry (INFIBIOC), Hospital de Clínicas José de San Martín, University of Buenos Aires, Buenos Aires, Argentina.; Varela NM; Latin American Network for the Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Santiago, Chile.; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago, Chile.; Lares-Asseff I; Latin American Network for the Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Santiago, Chile.; Academy of Genomics and Laboratory of Pharmacogenomics and Molecular Biomedicine, Instituto Politécnico Nacional, CIIDIR-Unidad Durango, Durango, Mexico.; Quiñones LA; Latin American Network for the Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Santiago, Chile.; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago, Chile.; Department of Pharmaceutical Science and Technology, Faculty of Chemical and Pharmaceutical Sciences, University of Chile, Santiago, Chile.

Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE

Medel-Jara P; Facultad de Medicina, Programa de Doctorado en Epidemiología, Pontificia Universidad Católica de Chile, Santiago, Chile.; Facultad de Medicina, Programa de Farmacología y Toxicología, Pontificia Universidad Católica de Chile, Santiago, Chile.; Facultad de Medicina, Carrera de Terapia Ocupacional, Pontificia Universidad Católica de Chile, Santiago, Chile.; Reyes Placencia D; Departamento de Gastroenterología, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.; Fuentes-López E; Facultad de Medicina, Departamento de Ciencias de la Salud, Pontificia Universidad Católica de Chile, Santiago, Chile.; Corsi O; Departamento de Gastroenterología, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.; Latorre G; Departamento de Gastroenterología, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.; Antón R; Digestive Medicine Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.; Biochemistry Department and Molecular Biology, Universidad de Valencia, Valencia, Spain.; Jiménez E; INCLIVA Biomedical Research Institute, Valencia, Spain.; Miralles-Marco A; INCLIVA Biomedical Research Institute, Valencia, Spain.; Caballero C; GenPat Laboratory, Asunción, Paraguay.; Boggino H; GenPat Laboratory, Asunción, Paraguay.; Cantero D; Endoscopy Department, Instituto de Previsión Social, Asunción, Paraguay.; Barros R; IPATIMUP - Institute of Pathology and Molecular Immunology of the University of Porto, Porto, Portugal.; Department of Pathology, Medical Faculty of the University of Porto, Porto, Portugal.; Santos-Antunes J; IPATIMUP - Institute of Pathology and Molecular Immunology of the University of Porto, Porto, Portugal.; Department of Gastroenterology, Centro Hospitalar Universitário de S. João, Porto, Portugal.; Department of Gastroenterology, Medical Faculty of the University of Porto, Porto, Portugal.; Díez M; Vall d'Hebron University, Barcelona, Spain.; Hospital-Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Quiñones LA; Faculty of Medicine, Department of Basic and Clinical Oncology, Laboratory of Chemical Carcinogenesis and Pharmacogenetics (CQF), University of Chile, Santiago, Chile.; Faculty of Chemical and Pharmaceutical Sciences, Department of Pharmaceutical Sciences and Technology, University of Chile, Santiago, Chile.; Latin American Network for Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF), Santiago, Chile.; Riquelme E; Departamento de Enfermedades Respiratorias, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.; Centro para la Prevención y el Control del Cáncer (CECAN), Santiago, Chile.; Rollán A; Facultad de Medicina Clínica Alemana-Universidad del Desarrollo, Unidad de Gastroenterología, Santiago, Chile.; Cerpa LC; Faculty of Medicine, Department of Basic and Clinical Oncology, Laboratory of Chemical Carcinogenesis and Pharmacogenetics (CQF), University of Chile, Santiago, Chile.; Latin American Network for Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF), Santiago, Chile.; Valdés I; Doctorate Program, Integrative Genomics, Universidad Mayor, Santiago, Chile.; Nyssen OP; Servicio de Aparato Digestivo. Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-Princesa), Universidad Autónoma de Madrid (UAM), Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain.; Moreira L; Hospital Clínic de Barcelona, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBERehd), IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), University of Barcelona, Barcelona, Spain.; Gisbert JP; Servicio de Aparato Digestivo. Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-Princesa), Universidad Autónoma de Madrid (UAM), Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain.; Camargo MC; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.; Ortiz-Olvera N; Departamento de Gastroenterología, UMAE, Hospital de Especialidades 'Dr. Bernardo Sepúlveda', Centro Médico Nacional Siglo XXI, IMSS, Ciudad de México, México.; Leon-Takahashi AM; Departamento de Gastroenterología, Instituto Nacional de Cancerología, Ciudad de México, México.; Ruiz-Garcia E; Departamento de Gastroenterología, Instituto Nacional de Cancerología, Ciudad de México, México.; Laboratorio de Medicina Traslacional, Instituto Nacional de Cancerología, Ciudad de México, México.; Fernández-Figueroa EA; Núcleo B de Innovación en Medicina de Precisión. Instituto Nacional de Medicina Genómica, Ciudad de México, México.; Garrido M; Centro de Oncología de Precisión, Escuela de Medicina, Universidad Mayor, Santiago, Chile.; Owen GI; Centro para la Prevención y el Control del Cáncer (CECAN), Santiago, Chile.; Faculty of Biological Sciences, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.; Millennium Institute on Immunology and Immunotherapy, Santiago, Chile.; Advanced Center for Chronic Diseases, Santiago, Chile.; Cervantes A; INCLIVA Biomedical Research Institute, Valencia, Spain.; Medical Oncology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.; Fleitas T; INCLIVA Biomedical Research Institute, Valencia, Spain.; Medical Oncology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain.; Riquelme A; Departamento de Gastroenterología, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.; Centro para la Prevención y el Control del Cáncer (CECAN), Santiago, Chile.

Publisher: Wiley Country of Publication: England NLM ID: 101606807 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2050-6414 (Electronic) Linking ISSN: 20506406 NLM ISO Abbreviation: United European Gastroenterol J Subsets: MEDLINE

Echeverría-Garcés G; Centro de Referencia Nacional de Genómica, Secuenciación y Bioinformática, Instituto Nacional de Investigación en Salud Pública 'Leopoldo Izquieta Pérez', Quito, Ecuador.; Latin American Network for the Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Santiago, Chile.; Ramos-Medina MJ; German Cancer Research Center (DKFZ), Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.; González A; Latin American Network for the Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Santiago, Chile.; Dasa Genómica Latam, Buenos Aires, Argentina.; Vargas R; Latin American Network for the Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Santiago, Chile.; Department of Molecular Biology, Galileo University, Guatemala City, Guatemala.; Cabrera-Andrade A; Escuela de Enfermería, Facultad de Ciencias de la Salud, Universidad de Las Américas, Quito, Ecuador.; Grupo de Bio-Quimioinformática, Universidad de Las Américas, Quito, Ecuador.; Armendáriz-Castillo I; Latin American Network for the Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Santiago, Chile.; García-Cárdenas JM; Latin American Network for the Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Santiago, Chile.; Laboratorio de Ciencia de Datos Biomédicos, Escuela de Medicina, Facultad de Ciencias Médicas de la Salud y de la Vida, Universidad Internacional del Ecuador, Quito, Ecuador.; Ramírez-Sánchez D; Cancer Research Group (CRG), Faculty of Medicine, Universidad de Las Américas, Quito, Ecuador.; Altamirano-Colina A; Cancer Research Group (CRG), Faculty of Medicine, Universidad de Las Américas, Quito, Ecuador.; Echeverría-Espinoza P; Cancer Research Group (CRG), Faculty of Medicine, Universidad de Las Américas, Quito, Ecuador.; Freire MP; Cancer Research Group (CRG), Faculty of Medicine, Universidad de Las Américas, Quito, Ecuador.; Ocaña-Paredes B; Cancer Research Group (CRG), Faculty of Medicine, Universidad de Las Américas, Quito, Ecuador.; Rivera-Orellana S; Cancer Research Group (CRG), Faculty of Medicine, Universidad de Las Américas, Quito, Ecuador.; Guerrero S; Latin American Network for the Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Santiago, Chile.; Laboratorio de Ciencia de Datos Biomédicos, Escuela de Medicina, Facultad de Ciencias Médicas de la Salud y de la Vida, Universidad Internacional del Ecuador, Quito, Ecuador.; Quiñones LA; Latin American Network for the Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Santiago, Chile.; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago, Chile.; Department of Pharmaceutical Sciences and Technology, Faculty of Chemical and Pharmaceutical Sciences, University of Chile, Santiago, Chile.; López-Cortés A; Cancer Research Group (CRG), Faculty of Medicine, Universidad de Las Américas, Quito, Ecuador.

Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101672560 Publication Model: eCollection Cited Medium: Print ISSN: 2405-8440 (Print) Linking ISSN: 24058440 NLM ISO Abbreviation: Heliyon Subsets: PubMed not MEDLINE

González-Martínez F; Faculty of Dentistry and Faculty of Exact Sciences, University of Cartagena, Colombia; Public Health Research Group, University of Cartagena, Colombia; Latin American Network for Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Santiago, Chile. Electronic address: fgonzalezm1@unicartagena.edu.co.; Johnson-Restrepo B; Faculty of Dentistry and Faculty of Exact Sciences, University of Cartagena, Colombia.; Quiñones LA; Latin American Network for Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Santiago, Chile; Laboratory of Chemical Carcinogenesis and Pharmacogenetics (CQF), Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Chile; Department of Pharmaceutical Science and Technology, School of Chemical and Pharmaceutical Sciences, University of Chile, Chile. Electronic address: lquinone@uchile.cl.

Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7709027 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-3169 (Electronic) Linking ISSN: 03784274 NLM ISO Abbreviation: Toxicol Lett Subsets: MEDLINE

Esperón P; Molecular Genetics Laboratory, Clinical Biochemistry Department, School of Chemistry, Universidad de la República, Montevideo, Uruguay.; Latin American Network for the Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Madrid, Spain.; Martínez MF; Latin American Network for the Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Madrid, Spain.; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago, Chile.; Redal MA; Latin American Network for the Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Madrid, Spain.; Genetic Division, Department of Medicine, INFIBIOC, Hospital de Clínicas José de San Martín, Buenos Aires University, Buenos Aires, Argentina.; Lazarowski A; Latin American Network for the Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Madrid, Spain.; Clinical Biochemistry Department, Hospital de Clínicas José de San Martín School of Pharmacy and Biochemistry, Institute for Research in Physiopathology and Clinical Biochemistry (INFIBIOC), University of Buenos Aires, Buenos Aires, Argentina.; López-Cortés A; Latin American Network for the Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Madrid, Spain.; Varela NM; Latin American Network for the Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Madrid, Spain.; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago, Chile.; Quiñones LA; Latin American Network for the Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Madrid, Spain.; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic-Clinical Oncology (DOBC), Faculty of Medicine, University of Chile, Santiago, Chile.

Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE

Owen GI; Department of Physiology, Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago 8331150, Chile.; Department of Hematology and Oncology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago 7820436, Chile.; Advanced Center for Chronic Diseases (ACCDiS), Santiago 8330034, Chile.; Millennium Institute on Immunology and Immunotherapy, Santiago 8331150, Chile.; Centro de Prevención y Control de Cáncer (CECAN), Santiago 8380453, Chile.; Cordova-Delgado M; Department of Physiology, Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago 8331150, Chile.; Department of Hematology and Oncology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago 7820436, Chile.; Faculty of Chemical and Pharmaceutical Sciences, Universidad de Chile, Santiago 8380494, Chile.; Bustos BI; Ken and Ruth Davee Department of Neurology, Simpson Querrey Center for Neurogenetics, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.; Cerpa LC; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic and Clinical Oncology, Faculty of Medicine, Universidad de Chile, Santiago 8380494, Chile.; Latin American Network for Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Santiago 8350499, Chile.; Gonzalez P; Department of Physiology, Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago 8331150, Chile.; Morales-Pison S; Centro de Oncología de Precisión (COP), Facultad de Medicina y Ciencias de la Salud, Universidad Mayor, Santiago 7560908, Chile.; Garcia-Bloj B; Centro de Oncología de Precisión (COP), Facultad de Medicina y Ciencias de la Salud, Universidad Mayor, Santiago 7560908, Chile.; Garrido M; Centro de Oncología de Precisión (COP), Facultad de Medicina y Ciencias de la Salud, Universidad Mayor, Santiago 7560908, Chile.; SAGA, Centro de Estudios Clínicos, Santiago 7610315, Chile.; Department of Oncología, Clínica Indisa, Santiago 7520440, Chile.; Miquel JF; Department of Gastroenterology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago 8330032, Chile.; Quiñones LA; Laboratory of Chemical Carcinogenesis and Pharmacogenetics, Department of Basic and Clinical Oncology, Faculty of Medicine, Universidad de Chile, Santiago 8380494, Chile.; Latin American Network for Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Santiago 8350499, Chile.; Department of Pharmaceutical Sciences and Technology, Faculty of Chemical and Pharmaceutical Sciences, University of Chile, Santiago 8380494, Chile.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101534003 Publication Model: Electronic Cited Medium: Print ISSN: 1999-4923 (Print) Linking ISSN: 19994923 NLM ISO Abbreviation: Pharmaceutics Subsets: PubMed not MEDLINE

Contreras-Castillo S; Laboratory of Chemical Carcinogenesis and Pharmacogenetics (CQF), Department of Basic and Clinical Oncology, Faculty of Medicine, University of Chile, Santiago, Chile.; Plaza A; Laboratory of Nephrology, Universidad Austral de Chile, Valdivia, Chile.; Stojanova J; Interdisciplinary Centre for Health Studies (CIESAL), Universidad de Valparaíso, Valparaíso, Chile.; Department of Clinical Pharmacology and Toxicology, St. Vincent's Hospital, Sydney, NSW, Australia.; Navarro G; Laboratory of Nephrology, Universidad Austral de Chile, Valdivia, Chile.; Carmona R; Laboratory of Nephrology, Universidad Austral de Chile, Valdivia, Chile.; Corvalán F; Laboratory of Chemical Carcinogenesis and Pharmacogenetics (CQF), Department of Basic and Clinical Oncology, Faculty of Medicine, University of Chile, Santiago, Chile.; Cerpa L; Laboratory of Chemical Carcinogenesis and Pharmacogenetics (CQF), Department of Basic and Clinical Oncology, Faculty of Medicine, University of Chile, Santiago, Chile.; Latin American Network for Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Madrid, Spain.; Sandoval C; Laboratory of Chemical Carcinogenesis and Pharmacogenetics (CQF), Department of Basic and Clinical Oncology, Faculty of Medicine, University of Chile, Santiago, Chile.; Muñoz D; Pharmacy Institute, Faculty of Sciences, Universidad Austral de Chile, Valdivia, Chile.; Leiva M; Laboratory of Nephrology, Universidad Austral de Chile, Valdivia, Chile.; Castañeda LE; Program of Human Genetics, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile, Santiago, Chile.; Farias N; Transplantation Unit, San Juan de Dios Hospital, Santiago, Chile.; Alvarez C; Transplantation Unit, San Juan de Dios Hospital, Santiago, Chile.; Llull G; Transplantation Unit, San Juan de Dios Hospital, Santiago, Chile.; Mezzano S; Laboratory of Nephrology, Universidad Austral de Chile, Valdivia, Chile.; Ardiles L; Laboratory of Nephrology, Universidad Austral de Chile, Valdivia, Chile.; Varela N; Laboratory of Chemical Carcinogenesis and Pharmacogenetics (CQF), Department of Basic and Clinical Oncology, Faculty of Medicine, University of Chile, Santiago, Chile.; Latin American Network for Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Madrid, Spain.; Rodríguez MS; Transplantation Unit, San Juan de Dios Hospital, Santiago, Chile.; Flores C; Laboratory of Nephrology, Universidad Austral de Chile, Valdivia, Chile.; Cayún JP; Laboratory of Chemical Carcinogenesis and Pharmacogenetics (CQF), Department of Basic and Clinical Oncology, Faculty of Medicine, University of Chile, Santiago, Chile.; Latin American Network for Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Madrid, Spain.; Krall P; Laboratory of Nephrology, Universidad Austral de Chile, Valdivia, Chile.; Departament of Pediatrics and Child Surgery, Faculty of Medicine, University of Chile, Santiago, Chile.; Quiñones LA; Laboratory of Chemical Carcinogenesis and Pharmacogenetics (CQF), Department of Basic and Clinical Oncology, Faculty of Medicine, University of Chile, Santiago, Chile.; Latin American Network for Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Madrid, Spain.

Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE